General Information

Government Type

State Agency

Entity

Department of Health and Human Services (DHHS)

Public Body

Pharmacy and Therapeutics Committee

Notice Information

Add Notice to Calendar

Notice Title

State Medicaid Pharmacy & Therapeutics Commitee

Notice Tags

Medicaid, Pharmacies

Notice Type(s)

Meeting

Event Start Date & Time

January 19, 2012 07:00 AM

Event End Date & Time

January 19, 2012 08:30 AM

Event Deadline Date & Time

01/12/12 06:00 PM

Description/Agenda

UTAH DEPARTMENT OF HEALTH STATE MEDICAID PHARMACY AND THERAPEUTICS COMMITTEE Thursday, January 19, 2012 7:00 a.m. to 8:30 a.m. Cannon Health Building Room 114 AGENDA Please note that persons who wish to address the P&T Committee may contact Lisa V. Hunt (lvhunt@utah.gov) at least 7 calendar days prior to the meeting. Comments from visitors, while welcome, may be limited due to time constraints 1. Welcome and Introductions..................................................Chair, Ellie Brownstein, M.D. a. Review and Approval of Minutes 2. Update on PDL Administration…………...............................................Lisa V. Hunt, R.Ph a. Housekeeping. 3. DUR Board Update.........................................................................................................N/A 4. Ophthalmic Anti-inflammatory Drugs Included agents: Bromfenac, Dexamethasone, Diclofenac, Difluprednate, Fluocinolone, Fluorometholone, Flurbiprofen, Ketorolac, Loteprednol, Nepafenac, PrednisoLONE, Rimexolone, Triamcinolone Documents: UU class review, UU list of available agents and dosage forms, UU summary of ophthalmic combination agents a. Over view of Clinical Outcomes…………….…………Melissa Archer, PharmD b. Other States Report…………………………………………. Lisa V. Hunt, R.Ph. c. Public Comment d. Board Discussion/Questions e. Board Action 5. Next Meeting Information………………………………………… Lisa V. Hunt, R.Ph. 6. Meeting Adjourned………………………………….........Chair, Ellie Brownstein, M.D. Public comment that responds to the materials presented by the College of Pharmacy @University of Utah is most helpful. The foundation documents used for most reviews are prepared by the Oregon Evidence-based Practice Center or the University of Utah College of Pharmacy and are posted in advance on the P&T Committee website. Manufacturers are requested to submit any additional materials they would like reviewed as part of the process to: Dr. Gary Oderda College of Pharmacy 30 South 2000 East SLC, UT 84112-5820 All materials must be clearly labeled that they are submitted for consideration as part of the state of Utah Medicaid Preferred Drug List Program review process. Materials must be received at least 60 days before the scheduled review date. Materials most useful to support the evidence-based process include any new evidence (information from clinical trials or studies when possible) after the Oregon monograph was prepared, unpublished materials the company would like considered as part of the process, or any other materials not likely to be included in a literature search. Utah Medicaid P&T Schedule 2012 January 2012 Ophthalmic Anti-inflammatory Drugs Included agents: Bromfenac, Dexamethasone, Diclofenac, Difluprednate, Fluocinolone, Fluorometholone, Flurbiprofen, Ketorolac, Loteprednol, Nepafenac, PrednisoLONE, Rimexolone, Triamcinolone Documents: UU class review, UU list of available agents and dosage forms, UU summary of ophthalmic combination agents February 2012 Oral Antivirals for HSV and CMV Included agents: Acyclovir, Famciclovir, Ganciclovir, Valacyclovir, Valganciclovir Antivirals for Influenza Included agents: Amantadine, Oseltamivir, Rimantadine, Zanamivir Documents: UU class reviews, UU list of available agents and dosage forms March 2012 Oral Immunosuppresive agents (mTOR Inhibitors, Calcineurin Inhibitors, Miscellaneous) Included agents: Azathioprine, Cyclosporine, Everolimus, Mycophenolate, Sirolimus, Tacrolimus Documents: UU class reviews, UU list of available agents and dosage forms, UU summary of miscellaneous agents April 2012 H2 Antagonists Included agents: Cimetidine, Famotidine, Nizatidine, Ranitidine Documents: UU class review, UU list of available agents and dosage forms May 2012 Prenatal Vitamin Agents Included agents: A-Free Prenatal [otc]; CitraNatal Harmony; CitraNatal 90 DHA; CitraNatal Assure; CitraNatal B-Calm; CitraNatal DHA; CitraNatal Rx; Concept DHA; Concept OB; Duet; Duet Balanced DHA; Femecal OB; Folcaps Care One; Foltabs Prenatal; Foltabs Prenatal Plus DHA; Gesticare; Gesticare DHA; KPN Prenatal [otc]; Mini-Prenatal [otc]; Multi-Nate 30; NataFort [otc]; Néevo; Néevo DHA; One A Day Women’s Prenatal [otc]; OptiNate; Paire OB Plus DHA; PreCare; PreferaOB; PreferaOB + DHA; PreferaOB One; Prenatabs FA; Prenatal One Daily [otc]; Prenatal Rx 1; Prenatal With Beta Carotene [otc]; Prenate DHA; Prenate Elite; Prenate Essential; PreNexa Premier; PrimaCare One; Select-OB; Stuart Prenatal [otc]; Tandem DHA; Tandem OB; TriCare Prenatal; TriCare Prenatal DHA One; Vinacal; Vinate Care; Vitafol-OB [otc]; Vitafol-OB+DHA [otc]; Vitafol-PN; VitaPhil + DHA Documents: UU class review, UU list of available agents and dosage forms June 2012 Antineoplastic Enzyme Inhibitors Included agents: Crizotinib, Dasatinib, Erlotinib, Gefitinib, Imatinib, Lapatinib, Nilotinib, Pazopanib, Ruxolitinib, Sorafenib, Sunitinib, Vandetanib Documents: UU class review, UU list of available agents and dosage forms July 2012 Antimetabolite Agents (Antifolate agents, Purine analogs, Pyrimidine analogs) Included agents: Capecitabine, Cladribine, Clofarabine, Cytarabine, Floxuridine, Fludarabine, Fluorouracil, Gemcitabine, Mercaptopurine, Methotrexate, Pemetrexed, Pentostatin, Pralatrexate, Thioguanine Documents: UU class review, UU list of available agents and dosage forms August 2012 Topical Steroids Included agents: Alclometasone, Amcinonide, Betamethasone, Clobetasol, Clocortolone, Desonide, Desoximetasone, Diflorasone, Fluocinolone, Fluocinonide, Flurandrenolide, Fluticasone, Halcinonide, Halobetasol, Hydrocortisone, Mometasone, Prednicarbate, Triamcinolone Documents: UU class review, UU list of available agents and dosage forms September 2012 Cold and Cough Agents Documents: UU class review, UU list of available agents and dosage forms

Notice of Special Accommodations (ADA)

LIsa Hunt, 801-538-6317

Notice of Electronic or Telephone Participation

No

Meeting Information

Meeting Location

288 North 1460 West
Cannon Health Building, Room 114
Salt Lake City, 84116
Show in Apple Maps Show in Google Maps

Contact Name

Ngan Huynh

Contact Email

nganhuynh@utah.gov

Contact Phone

801-538-6155

Notice Posting Details

Notice Posted On

January 11, 2012 02:54 PM

Notice Last Edited On

January 18, 2012 01:44 PM

Deadline Date

January 12, 2012 06:00 PM

Subscribe by Email

Subscription options will send you alerts regarding future notices posted by this Body.